Cephalalgia 2002-02-01

Effects of donitriptan on carotid haemodynamics and cardiac output distribution in anaesthetized pigs.

B Tom, P De Vries, J P C Heiligers, E W Willems, K Kapoor, G W John, P R Saxena

Index: Cephalalgia 22(1) , 37-47, (2002)

Full Text: HTML

Abstract

We investigated the effects of donitriptan, which possesses a uniquely high affinity and efficacy at 5-HT1B/1D receptors, on carotid and systemic haemodynamics in anaes thetized pigs. Donitriptan (0.16-100 microg kg(-1), i.v.) dose-dependently decreased total carotid blood flow and vascular conductance (maximum response: -25 +/- 3%). This effect was entirely due to a selective reduction in the cephalic arteriovenous anastomotic fraction (maximum response: - 63 +/- 3%; ED50%: 92 +/- 31 nmol/kg); the nutrient vascular conductance increased. Donitriptan did not decrease vascular conductances in or blood flow to a number of organs, including the heart and kidneys; in fact, vascular conductances in the skin, brain and skeletal muscles increased. Cardiac output was slightly decreased by donitriptan, but this effect was confined to peripheral arteriovenous anastomoses. The haemodynamic effects of donitriptan were substantially reduced by the 5-HT1B/1D receptor antagonist GR127935. These results show that donitriptan selectively constricts arteriovenous anastomoses via 5-HT1B receptor activation. The drug should be able to abort migraine headaches and it is unlikely to compromize blood flow to vital organs.


Related Compounds

Related Articles:

Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors.

2006-09-01

[Br. J. Pharmacol. 149(1) , 82-91, (2006)]

Donitriptan (Pierre Fabre).

2001-03-01

[Curr. Opin. Investig. Drugs 2(3) , 415-8, (2001)]

Comparison of contractile responses to donitriptan and sumatriptan in the human middle meningeal and coronary arteries.

2002-05-17

[Eur. J. Pharmacol. 443(1-3) , 125-32, (2002)]

An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system.

2001-05-01

[Pain 92(1-2) , 101-6, (2001)]

F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.

1999-07-01

[J. Pharmacol. Exp. Ther. 290(1) , 83-95, (1999)]

More Articles...